Caina Technology Co

Caina Technology Co Pre-Tax Margin

The Pre-Tax Profit Margin of Caina Technology Co (301122.SZ) as of Nov 14, 2026 is 0.37 %. In the previous year, Pre-Tax Profit Margin was 14.76 % — a change of -97.46% (lower).

Pre-Tax Margin

0.37 %

YoY

-97.46%

Last updated:

Pre-Tax Profit Margin of Caina Technology Co is 2025 0.37 % . Pre-Tax Profit Margin of Caina Technology Co was 2024 14.76 % . It decreases by -97.46% lower compared to the previous year.

The Caina Technology Co Pre-Tax Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Pre-Tax Margin
Date
Pre-Tax Margin
Jan 1, 2018
15.17 CNY
Jan 1, 2019
22.40 CNY
Jan 1, 2020
32.17 CNY
Jan 1, 2021
34.33 CNY
Jan 1, 2022
39.44 CNY
Jan 1, 2023
31.72 CNY
Jan 1, 2024
14.76 CNY
Jan 1, 2025
0.37 CNY
The Caina Technology Co Pre-Tax Margin history
YEARPre-Tax MarginYoY
0.37 %-97.46%
14.76 %-53.47%
31.72 %-19.57%
39.44 %+14.89%
34.33 %+6.70%
32.17 %+43.60%
22.40 %+47.70%
15.17 %+11.24%
13.63 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

Pre-Tax Profit Margin of Caina Technology Co is 0.37 % in 2025.

Pre-Tax Profit Margin of Caina Technology Co changed from 14.76 % to 0.37 %, representing a -97.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Pre-Tax Profit Margin Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

Pre-tax margin measures the percentage of revenue remaining after all expenses except income taxes. It isolates operational and financial performance from tax effects.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Pre-Tax Profit Margin's Caina Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Pre-Tax Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Pre-Tax Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Caina Technology Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Caina Technology Co